European Journal of Hospital Pharmacy

Papers
(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?60
Broad perspective on the relationship between soticlestat and QT interval in patients with epilepsy17
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease14
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients13
Advanced therapy medicinal products12
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years12
Antithrombotic stewardship: whether to stop anticoagulation after atrial fibrillation ablation11
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings11
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations11
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent11
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study11
Impact of CYP2C19 genotyping on clopidogrel therapy adjustments in patients with stroke or TIA9
Is standard induction with mirikizumab sufficient in refractory ulcerative colitis in real-world practice?9
Empowering European hospital pharmacists in the face of heart failure9
EJHP’s impact factor moves on up8
Hypoglycaemic coma induced by a falsified semaglutide product: a case report7
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology7
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze7
The threatened medicines information pharmacist!7
Expanded expiry dates: a regulatory opportunity for Europe7
Correspondence on “Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements7
The end of an era!6
Drug–drug interactions in adjuvant and neoadjuvant breast cancer therapy6
Business continuity plans for hospital pharmacies: a Delphi consensus6
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts6
177Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods6
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey6
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report6
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report6
Optimisation of the quality of care for patients with severe asthma: ASfarMA project6
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings6
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations5
EMA guidance for industry to prevent and mitigate medicine shortages5
Pharmaceutical validation of peripherally inserted central catheters: four years of implementation5
Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care5
Thoughts on the shortage of vinflunine: could we have done more?5
Challenges and opportunities for hospital pharmacists in the management of gene and cell therapies5
Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipi5
Beta-lactam allergy in patients: an antibiotic stewardship challenge5
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report5
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients5
Response to: Correspondence on ‘Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake5
Risk factors for unintentional medication discrepancies identified through pharmacy staff-led medication reconciliation to prioritise patients in the emergency department: a rapid review4
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy4
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report4
Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review4
Drug-induced acute generalised exanthematous pustulosis: insights from FAERS data on a rare but severe cutaneous adverse reaction4
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis4
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C4
Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements4
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach4
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies4
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness4
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence4
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab4
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 20234
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time4
Medicinal mushrooms and chemotherapy: therapeutic synergy or hidden risk?4
Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database3
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients3
Medication adherence interventions: where are we and where do we go?3
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey3
An antidote network in Spain, a tool to improve antidote availability in hospitals3
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags3
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-193
The future of pharmacy is already here: can we afford not to invest? Reflections from the seventh EAHP Synergy Certification Course 2025 in Bratislava3
Switching of anti-migraine antibodies: effectiveness or regression to the mean?3
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management3
Penicillin allergy that persisted after 66 years: case report3
Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report3
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports3
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document3
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients3
Organisational impact of in vivo gene therapies at two French injection centres3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 20223
Update on the hospital pharmacist profile: from clinical practice to management3
Pharmacological resilience in the context of geopolitical tensions: a European perspective3
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings3
Hypomagnesaemia with niraparib: the need for comprehensive adverse effect reporting in drug labelling3
Clinical trials3
Fully validated HPLC-UV detection method associated with colour variation control for evaluation of the stability of 5-fluorouracil chemotherapy polyolefin infusion bags at dose banding3
Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit3
Systematic review of independent pharmacist prescribing for the treatment of cardiometabolic factors in chronic non-communicable diseases3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing3
Capecitabine: guaranteed access in adjuvant treatment of breast cancer3
Infectious diseases and antimicrobial resistance3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology3
Medication adherence in chronic myeloid leukemia: a hospital pharmacy-level analysis2
Medication-related problems in critical care survivors: a systematic review2
Capillary electrophoresis in parenteral nutrition control – validation of two analytical methods: Amino acids/glucose/glucose-1-phosphate and K/Na/Ca/Mg2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation2
Factors associated with potential drug–drug interactions in psychiatric inpatients2
European health data space proposal launched2
Pharmacist-led patient education improves medication self-management and adherence in chronic hepatitis D virus patients: insights from the EXPLAIN project2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia2
To maximise impact, hospital pharmacists need to increase visibility2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study2
Do junior doctors make more prescribing errors than experienced doctors when prescribing electronically using a computerised physician order entry system combined with a clinical decision support syst2
Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin2
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 12
Results of EAHP’s 2023 shortages survey2
Patient safety culture and medication safety in European intensive care units: a focus group study2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review2
Safeguarding antimicrobial medicines reserved for treating humans2
Introduction to an online only issue2
Defining a new term: defensive hospital pharmacy practices2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins2
Association of acamprosate versus gabapentinoids with liver disease progression and alcohol-related admissions in patients with alcohol use disorder2
Looking back and looking forward2
Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials2
Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration2
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?2
Home antibiotic therapy in elastomeric infusion pumps – past, present and future2
Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach” by Protze2
Using local clinical rules in a pharmacy service to detect risk prescriptions in older adult hospital inpatients: a proof-of-concept study2
Evaluation of resources for effective decision-making about drug manipulation2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding2
Realising potential and addressing risk: a UK survey of adult hepatology pharmacy services2
Comparison of the 22nd World Health Organization Model List of Essential Medicines with the explicit criteria for the treatment of chronicity in elderly patients2
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques2
When gravimetry is debated by sponsors of clinical studies2
The secret life of the surgical pharmacy in high risk periods2
Drug intoxication: a silent obstacle to organ donation2
Ceftaroline combination therapy for methicillin resistant coagulase negative Staphylococcus bacteraemia and endocarditis2
Public information on shortages in the EU/EEA: improvements made between 2018 and 20202
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals2
Comparison of adverse drug reactions of statins in China from 1989 to 20192
Unit dose drug dispensing systems in hospitals: a systematic review of medication error reduction and cost-effectiveness2
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?2
Digital health2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment2
Study of therapeutic patient education practices in French renal transplantation centres2
Liquid antimicrobials: a national analysis of critical shortages2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy2
Implementation of pharmacists’ monitoring for intravenous drug compatibility2
0.083754062652588